Company: NMP
Filing Date: 2025-02-10
Form Type: DRS
Source: 0001213900-25-011477
Chunk: 119

Company: NMP Acquisition Corp.
Filing Date: 2025-02-10
Form: DRS
Chunk 119
---
, except if we increase the size of the offering, in which case we will effect a capitalization or share dividend or other appropriate mechanism immediately prior to the consummation of the offering in such amount as necessary to maintain the ownership of our sponsor prior to this offering at 25% of our issued and outstanding ordinary shares upon the consummation of this offering (excluding the private placement shares and representative shares) or approximately 25.7% (including the private placement shares and the representative shares). Further, if we incur any indebtedness in connection with our initial business combination, our ability to declare dividends may be limited by restrictive covenants we may agree to in connection therewith. 75

DILUTION The difference between the public offering price per ordinary share, assuming no value is attributed to the rights included in the units we are offering pursuant to this prospectus, or the private placement rights, and the pro forma net tangible book value per ordinary share after this offering constitutes the dilution to investors in this offering. Such calculation does not reflect any dilution associated with the sale and exercise of rights, including the private placement rights, which would cause the actual dilution to the public shareholders to be higher, particularly where a cashless exercise is utilized. Net tangible book value per share is determined by dividing our net tangible book value, which is our total tangible assets less total liabilities (including the value of ordinary shares which may be redeemed for cash), by the number of outstanding ordinary shares. The following table illustrates the difference between the public offering price and our net tangible book value (“NTBV”), as adjusted to give effect to this offering and to redemptions of our public shares at varying levels, assuming the full exercise and no exercise of the over -allotmentoption. The below calculations (A) assume that (i) no ordinary shares are issued to shareholders of a potential business combination target as consideration or issuable by a post -businesscombination company, for instance under an equity or employee share purchase plan, (ii) no ordinary shares and convertible equity or debt securities are issued in connection with additional financing that we may seek in connection with an initial business combination, and (iii) no working capital loans, if applicable, are converted into private placement units, as further described in this prospectus, and (B) assumes the issuance of 10,000,000 Class A ordinary shares (or 11,500,000 Class A ordinary shares if the underwriters’ over -allotmentoption is exercised in full), 400